Last Price
0.046
Today's Change
-0.006 (11.53%)
Day's Change
0.04 - 0.055
Trading Volume
920,321
Overview
Market Cap
2 Million
Shares Outstanding
43 Million
Avg Volume
3,789,504
Avg Price (50 Days)
0.23
Avg Price (200 Days)
0.81
PE Ratio
0.00
EPS
-94.13
Earnings Announcement
21-Feb-2024
Previous Close
0.05
Open
0.05
Day's Range
0.04 - 0.055
Year Range
0.04 - 7.64
Trading Volume
920,321
Price Change Highlight
1 Day Change
-11.54%
5 Day Change
-24.59%
1 Month Change
-70.32%
3 Month Change
-89.71%
6 Month Change
-91.14%
Ytd Change
-98.67%
1 Year Change
-99.17%
3 Year Change
-100.00%
5 Year Change
-100.00%
10 Year Change
-100.00%
Max Change
-100.00%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMBA, which is in phase I clinical trial; BX3000, an NMBA reversal agent; and Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Trending Events
Apps
Top Articles
1
NordFX Weekly Forecast
Forex and Cryptocurrencies Forecast for November 27 – December 01, 2023
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
